日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.

解码非小细胞肺癌围手术期化疗免疫疗法完全病理反应的 B 细胞特征。

Sierra-Rodero Belén, Gil-González Ángeles, Molina-Alejandre Marta, Nadal Ernest, Calvo Virginia, Lázaro Martín, Insa Amelia, Massuti Bartomeu, Martinez Marti Alex, de Castro Javier, García Campelo Rosario, González Larriba Jose Luis, Bernabé Reyes, Dómine Manuel, Ponce Aix Santiago, Cobo Manuel, Camps Carlos, Reguart Noemi, Bosch-Barrera Joaquím, Majem Margarita, Aguilar Andres, Palmero Ramón, Blanco Clemente Mariola, Martín-López Javier, Muñoz-Viana Rafael, Megías Diego, Gutiérrez-Escobedo Juan Manuel, Martínez-Toledo Cristina, Cruz-Bermúdez Alberto, Provencio Mariano

Carcinogenicity of atrazine, alachlor, and vinclozolin

阿特拉津、甲草胺和乙烯菌核利的致癌性

Cattley, Russell C; De Roos, Anneclaire J; Mandrioli, Daniele; Pearce, Neil; Pronk, Anjoeka; Soshilov, Anatoly; Abarikwu, Sunny O; Baldi, Isabelle; Barr, Dana B; Freeman, Laura E Beane; Bortoli, Sylvie; Connolly, Alison; Dalvie, Mohamed A; Ferreira, Marcelo Jm; Genter, Mary Beth; Le Hégarat, Ludovic; Lorenzetti, Stefano; McLaughlin, John R; Møller, Peter; Montagner, Cassiana C; Silveira, Henrique C S; Toyoda, Takeshi; Volle, David H; Benbrahim-Tallaa, Lamia; de Conti, Aline; Facchin, Caterina; Kunzmann, Andrew T; Madia, Federica; Pasqual, Elisa; Aix, Marie-Laure; Deng, Xiaobei; Dongoran, Rachmad A; Olanipekun, Michael T; Suonio, Eero; Viegas, Susana; Mattock, Heidi; Wedekind, Roland; Schubauer-Berigan, Mary K

Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies

了解并克服FGFR2驱动型恶性肿瘤对选择性FGFR抑制剂的耐药性

Francesco Facchinetti ,Yohann Loriot ,Floriane Brayé ,Damien Vasseur ,Rastislav Bahleda ,Ludovic Bigot ,Rémy Barbé ,Catline Nobre ,David Combarel ,Stefan Michiels ,Antoine Italiano ,Cristina Smolenschi ,Lambros Tselikas ,Jean-Yves Scoazec ,Santiago Ponce-Aix ,Benjamin Besse ,Fabrice André ,Ken A Olaussen ,Antoine Hollebecque ,Luc Friboulet

Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021)

卡博替尼联合阿特珠单抗治疗既往未接受治疗的晚期肝细胞癌以及既往接受过治疗的胃癌和胃食管交界处腺癌:一项多中心、开放标签、1b期试验(COSMIC-021)的两个扩展队列的结果

Li, Daneng; Loriot, Yohann; Burgoyne, Adam M; Cleary, James M; Santoro, Armando; Lin, Daniel; Aix, Santiago Ponce; Garrido-Laguna, Ignacio; Sudhagoni, Ramu; Guo, Xiang; Andrianova, Svetlana; Paulson, Scott

Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer

FGFR驱动的尿路上皮癌对选择性FGFR抑制剂的耐药性

Francesco Facchinetti ,Antoine Hollebecque ,Floriane Braye ,Damien Vasseur ,Yoann Pradat ,Rastislav Bahleda ,Cédric Pobel ,Ludovic Bigot ,Olivier Déas ,Juan David Florez Arango ,Giorgia Guaitoli ,Hayato Mizuta ,David Combarel ,Lambros Tselikas ,Stefan Michiels ,Sergey I Nikolaev ,Jean-Yves Scoazec ,Santiago Ponce-Aix ,Benjamin Besse ,Ken A Olaussen ,Yohann Loriot ,Luc Friboulet

Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial

纳武利尤单抗治疗既往接受过治疗的B3型胸腺瘤和胸腺癌患者的疗效和安全性:来自EORTC-ETOP NIVOTHYM II期试验的结果

Girard, N; Ponce Aix, S; Cedres, S; Berghmans, T; Burgers, S; Toffart, A-C; Popat, S; Janssens, A; Gervais, R; Hochstenbag, M; Silva, M; Burger, I A; Prosch, H; Stahel, R; Xenophontos, E; Pretzenbaher, Y; Neven, A; Peters, S

Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results

在既往未接受治疗的EGFR突变转移性非小细胞肺癌患者中,雷莫芦单抗联合厄洛替尼与安慰剂联合厄洛替尼的疗效比较(RELAY):二代测序结果的探索性分析

Garon, E B; Reck, M; Nishio, K; Heymach, J V; Nishio, M; Novello, S; Paz-Ares, L; Popat, S; Aix, S Ponce; Graham, H; Butts, B D; Visseren-Grul, C; Nakagawa, K

From N-of-one to series of exceptional responders: unlocking the mystery of outliers in oncology

从个例研究到一系列异常反应者:揭开肿瘤学异常值之谜

Rodriguez, J E; Ponce-Aix, S

Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC

阿维鲁单抗联合西妥昔单抗和化疗作为晚期鳞状非小细胞肺癌患者的一线治疗方案

Andric, Zoran; Gálffy, Gabriella; Cobo Dols, Manuel; Szima, Barna; Stojanovic, Goran; Petrovic, Marina; Felip, Enriqueta; Vicente Baz, David; Ponce Aix, Santiago; Juan-Vidal, Oscar; Szalai, Zsuzsanna; Losonczy, Gyorgy; Calles Blanco, Antonio; Bernabe, Reyes; García Ledo, Gema; Aguilar Hernández, Andrés; Duecker, Klaus; Zhou, Dongli; Schroeder, Andreas; Guezel, Guelseren; Ciardiello, Fortunato

A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer

一项针对实体瘤和非小细胞肺癌的 galunisertib 联合 nivolumab 的 Ib/II 期研究

Nadal, Ernest; Saleh, Mansoor; Aix, Santiago Ponce; Ochoa-de-Olza, Maria; Patel, Sandip Pravin; Antonia, Scott; Zhao, Yumin; Gueorguieva, Ivelina; Man, Michael; Estrem, Shawn T; Liu, Jiangang; Avsar, Emin; Lin, Wen Hong; Benhadji, Karim A; Gandhi, Leena; Guba, Susan C; Diaz, Inmaculada Ales